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Heparan sulfate and heparin are highly sulfated polysac-
charides that consist of a repeating disaccharide unit of glu-
cosamine and glucuronic or iduronic acid. The 2-O-sulfated
iduronic acid (IdoA2S) residue is commonly found in
heparan sulfate and heparin; however, 2-O-sulfated glucuron-
ic acid (GlcA2S) is a less abundant monosaccharide (<5%
of total saccharides). Here, we report the synthesis of three
GlcA2S-containing hexasaccharides using a chemoenzymatic
approach. For comparison purposes, additional IdoA2S-con-
taining hexasaccharides were synthesized. Nuclear magnetic
resonance analyses were performed to obtain full chemical
shift assignments for the GlcA2S- and IdoA2S-hexasacchar-
ides. These data show that GlcA2S is a more structurally
rigid saccharide residue than IdoA2S. The antithrombin (AT)
binding affinities of a GlcA2S- and an IdoA2S-hexasaccharide
were determined by affinity co-electrophoresis. In contrast to
IdoA2S-hexasaccharides, the GlcA2S-hexasaccharide does
not bind to AT, confirming that the presence of IdoA2S is crit-
ically important for the anticoagulant activity. The availabil-
ity of pure synthetic GlcA2S-containing oligosaccharides will
allow the investigation of the structure and activity relation-
ships of individual sites in heparin or heparan sulfate.
Keywords: chemoenzymatic synthesis / heparan
sulfate / heparin / oligosaccharides / sulfotransferase
Introduction
Proteoglycans mediate many protein functions and physiologi-
cal processes ranging from cell development, differentiation,
inflammation, viral or parasite infection, metastasis to cancer
(Bishop et al. 2007). Proteoglycans consist of a core protein and
various glycosaminoglycans (GAG) side chains. Although the
amino acid sequence of the core protein is encoded by a specific
gene, the GAG side chains are generated by a non-template en-
zymatic process (Feyerabend et al. 2006; Carlsson et al. 2008;
Victor et al. 2009). Heparin and heparan sulfate (HS) are
members of this polysulfated GAG family.
Heparin, a widely used clinical anticoagulant since the
1930s, was the first biopolymeric drug and is one of the few
carbohydrate based drugs (Linhardt 2003; Liu et al. 2009).
Because of the heterogeneity of heparin sequences, understand-
ing the contribution of a specific sulfated carbohydrate se-
quence for a given biological activity remains challenging.
Heparin is a mixture of polysaccharides and has high polydis-
persity and polyheterogeneity (Linhardt 2003) as well as flex-
ible structural characteristics (Liu et al. 2009). In addition,
heparin is a highly sulfated polysaccharide with an average mo-
lecular weight of 17 kDa (Sommers et al. 2011) and with a
range of chain lengths from 5000 to 50,000 Da (Ahsan et al.
1995). Heparin has repeating disaccharide units consisting of
uronic acid (L-iduronic acid, IdoA or D-glucuronic acid, GlcA)
linked 1→ 4 to D-glucosamine (GlcN) (Casu 1985), where the
glucosamine residues can be either N-acetylated (GlcNAc) or
sulfated (GlcNS). The GlcN monosaccharide can also contain
O-sulfo groups, including 6-O- and 3-O-sulfation, while the
GlcA and IdoA residues can be 2-O-sulfated. Heparan sulfate
(HS) is structurally analogous to heparin. HS has a similar disac-
charide repeating structure to heparin with some noticeable dif-
ferences. Generally, the HS chains are longer with an average
MW of 30 kDa (Griffin et al. 1995), and HS contains a higher
GlcA content and less sulfation than heparin (Linhardt 2003). In
addition, heparan sulfate has more diverse sulfated saccharide
sequences and domain structures compared with heparin.
Reliable structural characterization techniques are critically
important to safeguard the quality of heparin drugs. In 2008,
batches of contaminated heparin were discovered in United
States which drew significant public attention because the con-
taminated drug killed 94 patients in United States (McMahon
et al. 2010). Nuclear magnetic resonance (NMR) techniques
were employed and rapidly identified the nature of the contam-
inant to be over sulfated chondroitin sulfate. This demonstrated
the important role of NMR measurements in heparin quality
control (Liu et al. 2009). NMR data provide structural informa-
tion that cannot be obtained by other methods, specifically
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epimer recognition, anomeric configuration identification, sul-
fated position determination and conformation and secondary
structure determination. One limitation in utilizing NMR to
analyze the structure of heparin or HS is that these species are a
mixture of compounds and pure oligosaccharide standards have
not been available. Although certain oligosaccharides have
been isolated from partially depolymerized heparin or HS,
obtaining sufficient amounts of those highly purified oligosac-
charides is a difficult and time-consuming process.
Recently, a new method using recombinant HS biosynthetic
enzymes to prepare structurally homogeneous HS oligosacchar-
ides was developed (Xu et al. 2011). This method allows the
synthesis of a series of structurally homogeneous heparin or HS
oligosaccharides at the scale of tens to hundreds of milligram
with high yield. Access to highly purified HS oligosaccharides
allows for full-scale analyses of these complex molecules by
NMR. Notably, these synthetic compounds enable the analysis
of structurally “rare” oligosaccharides which are difficult to
isolate in sufficient quantity for NMR analysis. For example,
the -GlcA2S- residue represents only 1–5% of total uronic acid
in heparin isolated from natural sources (Guerrini and Torri
2008).
Here, to address this knowledge gap of the structure charac-
teristics of these potentially important oligosaccharide species,
we report the NMR analysis of a series of GlcA2S-containing
hexasaccharides with different sulfation patterns. The GlcA2S
oligosaccharides were prepared by a chemoenzymatic ap-
proach. The GlcA2S NMR data were compared with the data
obtained from 2-O-sulfated iduronic acid (IdoA2S)-containing
oligosaccharides synthesized by the same method. The data
confirm previous assignments for the NMR signals of GlcA2S
saccharides (Guerrini and Torri 2008).
Results
Chemoenzymatic synthesis of GlcA2S- and
IdoA2S-containing hexasaccharides
Total of eight hexasaccharide Constructs 1–8 were synthesized
in this study using a chemoenzymatic approach (Figure 1). The
synthesis was initiated from a commercially available mono-
saccharide, 1-O-(para-nitrophenyl) glucuronide (GlcA-pnp),
requiring elongation steps, sulfation and epimerization steps
(Supplementary data, Figure S1) (Xu et al. 2011). In the synthe-
sis, a hexasaccharide with a structure of GlcNTFA-GlcA-GlcNS-
GlcA-GlcNS-GlcA-pnp is a crucial intermediate (Supplementary
data, Figure S1). The N-trifluoroacetyl group of this hexasacchar-
ide intermediate was hydrolyzed to yield Construct 1 by treatment
with lithium hydroxide. Then this hexasaccharide intermediate
was treated with a mixture of C5-epi and 2-O-sulfotransferase
(OST) to yield a mixture of GlcA2S- and IdoA2S-intermediate
(Supplementary data, Figure S1). An anion-exchange HPLC
method was used to isolate and purify these two products with
a ratio of 1:9 (Figure 2A). After the purification, a GlcA2S-
intermediate was obtained with the purity >93% as determined
by anion-exchange HPLC (Figure 2B). Similarly, an IdoA2S-
intermediate was obtained with the purity >96% (Figure 2C).
The GlcA2S-intermediate was further converted to Construct 2
by detriflouroacetylation under an alkaline condition. Additional
modifications were made, including N-sulfation and 6-O-sulfation,
yielded to Constructs 3 and 4, respectively. Similarly, the
IdoA2S-intermediate was transformed to Constructs 5, 6 and 7.
3-O-Sulfation was carried out on Construct 7 to form Construct
8. The purity analysis of each synthesized oligosaccharide and
mass spectrometric analyses are shown in Supplementary data,
Figures S2 and S3.
NMR analysis of hexasaccharides
The availability of high-purity structurally defined hexasacchar-
ides provided us sufficient quantities for NMR analyses. The
1H NMR spectra of GlcA-containing hexasaccharide (Construct
1) and GlcA2S-containing hexasaccharides, including Constructs
2, 3 and 4, are shown in Figure 3; the 1H NMR spectra of
IdoA2S-containing hexasaccharides, including Constructs 5–8,
are shown in Figure 4. The proton signals from the saccharide
residues are highly overlapped and this makes the chemical
shift assignment difficult. Therefore, 2D-homonuclear and
-heteronuclear correlation spectroscopy analyses (1H–1H COSY,
TOCSY, 1H–13C HSQC and HMBC) were conducted; these ana-
lyses only partially resolved the overlapped signals. Thus, 2D
1H–13C HSQC–TOCSY NMR experiments (Figure 5) were
employed to resolve these overlapped signals. The full proton
and carbon chemical shift assignments for Constructs 1–8 are
listed in Tables I and II.
Characterization of GlcA2S-containing oligosaccharides
Here, we use Construct 3 (with the structure of GlcNS-
GlcA-GlcNS-GlcA2S-GlcNS-GlcA-pnp) to demonstrate how
the signals of GlcA2S were identified in the synthetic oligosac-
charides. In the 1H NMR spectrum of Construct 3, the signals
from anomeric protons of the three GlcNS units are located
5.6 ppm and the signals from GlcA/GlcA2S are located
4.6 ppm (Figure 3). The 5.3 ppm shift of I-1 is attributed to
the effect of the nearby electron withdrawing group, para-
nitrophenyl (pnp). The 3JHH coupling constants of I-1, III-1
and V-1 were 8 Hz (consistent with β linkages), and II-1,
IV-1 and VI-1 were 4 Hz (consistent with α linkages). Other
saccharide ring proton signals were highly overlapped and reso-
nated between 3.2 and 4.1 ppm. The increased shift dispersion
in 2D 1H–13C HSQC–TOCSY NMR, fully resolved these
signals so that assignments could be made (Figure 5). In add-
ition, longer 1H–1H COSY and 1H–13C HSQC experiments
were run with more points in the indirect dimension for better
digital resolution which allowed more accurate identification of
the proton and carbon assignments (Table I). The assignments
for other GlcA2S-containing hexasaccharides were conducted
in a similar manner.
The 2D–1H–13C HMBC experiment confirmed the glycosid-
ic linkages between each saccharide unit through 3J correlations
between the anomeric II-1, III-1, IV-1, V-1 or VI-1 protons
show connectivity to the I-4, II-4, III-4, IV-4 or V-4 carbons, re-
spectively (Figure 6). These connectivities allowed sequencing
of the hexasaccharides. In addition, the anomeric I-1 proton
shows a 3JCH-correlation with the quaternary carbon of the pnp
tag. Furthermore, the II-6, IV-6 or VI-6 protons shows through-
bond connectivity to II-4, IV-4 or VI-4 carbons, respectively,
supporting the assignments of glucosamine residues. The other
GlcA2S-containing hexasaccharides were characterized by fol-
lowing the same approach. In addition to 1H–1H COSY and
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Fig. 1. The synthetic hexasaccharide Constructs 1–8. A total of eight synthetic hexasaccharides were prepared in this study.
Fig. 2. Two major products of epimerization and 2-O-sulfation. (A) The anion-exchange HPLC chromatogram after epimerization/2-O-sulfation of hexasaccharide
intermediate. The product contains 10% GlcA2S-intermediate and 90% IdoA2S-intermediate. (B and C) The anion-exchange HPLC chromatogram of GlcA2S- and
IdoA2S-intermediate after purification. The purity is >93 and 96%, respectively. The chemical structure of GlcA2S- and IdoA2S-intermediate is shown on right of
(B) and (C).
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1H–13C HSQC experiments, we focused on using 2D 1H–13C
HSQC–TOCSY NMR to identify the residue spin systems and 2D
1H–13C HMBCNMR to confirm the linkages (Figure 3, Table I).
Comparing the NMR spectra of Construct 1 with Construct 2
provides evidence of the influence of 2-O-sulfation on the
neighboring residues (Figure 3). The signals of III-1, III-2 and
III-3 from Construct 2 are shifted +0.17, +0.73 and +0.17 ppm
(to 4.70, 4.11 and 4.02 ppm), respectively, due to the attached
2-O-sulfo group. Notably, the shift of proton II-1 (−0.12 ppm),
II-6b (+0.11 ppm) and VI-2 (−0.15 ppm) are also sensitive to
2-O-sulfation even though they are distant from the site of sub-
stitution. The chemical shift changes observed for the II residue
are attributed to interresidue influences between this additional
2-O-sulfo group and cationic groups. The effect on VI-2 may
be due to the interactions between the positive charge from the
unsubstituted amino group to the nearby 2-O-sulfo group. The
8 Hz axial–axial proton coupling constants of the III residue
remain unchanged, indicating that the GlcA2S conformation
remains predominately in the 4C1 form in Construct 2 and is the
same as GlcA in Construct 1 (Sattelle et al. 2010).
To reveal the structural flexibility of GlcA2S and IdoA2S
residues, we compared the proton spectra of GlcA2S- with
IdoA2S-containing hexasaccharides, focusing on the signals of
the Residue III. The values of the 3JHH coupling constant
reflect altered saccharide conformation. The coupling constant
(doublet, 8.0 Hz) of III-1 signal of GlcA2S in Construct 2
remains the same as that in Constructs 3 and 4, suggesting that
the conformation of GlcA2S is relatively unaffected by the
extra sulfo groups (Figure 3). This result is consistent with that
GlcA2S predominately maintain the 4C1 conformation as GlcA
in Construct 1 (Sattelle et al. 2010). We observed that broad
signals for IdoA2S (residue III) (Figure 4). The addition of
EDTA significantly sharpened the IdoA2S signals (Supple-
mentary data, Figure S5). The spectra show the coupling con-
stants of III-1 signals are altered in different IdoA2S-containing
constructs. Similarly, the coupling constants of III-5 signals are
also sensitive to different sulfation patterns, suggesting that
conformational distribution of IdoA2S is affected by different
sulfation pattern. For example, the 3JHH coupling constants of
III-1 (2.2 Hz) and III-5 (2.2 Hz) signal in Construct 5 are
increased to (3.7 Hz) and (3.1 Hz) in Construct 8 due to the
presence of additional sulfo groups. These changes are attribu-
ted to greater structural flexibility of IdoA2S residue compared
to GlcA2S in these constructs. This result is consistent with the
Fig. 3. 1H NMR spectra of Constructs 1–4. (A–D) The 1H NMR spectrum of Constructs 1–4, respectively. The signals of anomeric protons and some
non-overlapping protons are indicated. The chemical structure of construct is shown on top of each panel. The 1H NMR spectra represent the range between 3.1 and
5.7 ppm.
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previous reports that IdoA2S equilibrates between 2S0 (skew
boat) and 1C4 (chair) conformers (Ferro et al. 1990; Sattelle
et al. 2010). Although the addition of EDTA did not consider-
ably change the chemical shifts of IdoA2S-containing hexasac-
charides, some changes were noted for Construct 5. In
Construct 5, the VI-2 proton signal shifted by 0.19 ppm with
addition of 3 mM EDTA under the same conditions (pD 7.0,
25°C). Similarly, the signals of VI-1 and VI-3 were altered as
well (Supplementary data, Table S1).
The presence of GlcA2S or IdoA2S also impacted the chem-
ical environment of neighboring saccharide residues. We com-
pared the signals from each proton of GlcA2S- and IdoA2S-
containing hexasaccharides (Table III). As expected, signals from
Residue III displayed the largest difference in chemical shifts.
Outside Residue III, significant differences in the chemical shifts
were observed for the protons of Residue II (II-1, II-3 and II-6),
and protons of Residue IV (IV-1 and IV-5) (Table III). For
example, comparing the IV-1 proton in Constructs 2 and 5, the
signals are shifted by 0.34 ppm. Similarly, between Constructs 3
and 6 the IV-1 proton was shifted by 0.32 and 0.22 ppm between
Constructs 4 and 7, respectively. These data suggest the presence
of GlcA2S or IdoA2S has different effects on the chemical envir-
onment of neighboring residues. Beyond Residues II and IV,
chemical shift differences between GlcA2S- and IdoA2S-
hexasaccharides diminished significantly. Some differences in
chemical shifts were observed from Residue VI, an N-unsubstituted
glucosamine residue in Constructs 2 and 5, suggesting that the
presence of a primary amino group (–NH2) of this end residue
is sensitive to GlcA2S vs IdoA2S residues.
Intramolecular effects by N-sulfation, 6-O-sulfation and
3-O-sulfation
Comparing the chemical shifts of the signals from hexasacchar-
ides bearing N-unsubstituted vs N-sulfated Residue VI suggests
the intramolecular interaction between the N-sulfo groups and
the GlcA residue at its reducing end. The chemical shifts of the
V-3 signals in Constructs 2 and 3 are shifted by +0.08 ppm;
similarly, the signals of the V-3 protons in Constructs 5 and 6
are shifted +0.10 ppm (Tables I and II). These effects may be
attributed to the function of the acidic sulfo group masking the
basic amino group on the VI residue and altering the chemical
environment around the V residue. These observations are con-
sistent with molecular dynamics simulation results that showed
an interaction between the N-sulfo group of Residue VI and the
V-3 position of Residue V as proposed by Langeslay et al.
Fig. 4. 1H NMR spectra of Constructs 5–8. (A–D) The 1H NMR spectrum of Constructs 5–8, respectively. The signals of anomeric protons and some
non-overlapping protons are indicated. The chemical structure of construct is shown on top of each panel. The 1H NMR spectra represent the range between 3.1 and
5.7 ppm.
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(2012) for fondaparinux. Another interesting observation is
the impact of N-sulfation on the chemical shift of VI-2 signals.
In GlcA2S-containing hexasaccharides, N-sulfation shifts the
VI-2 signal to higher parts per million (+0.06 ppm) due to the
effects of de-shielding (less local electron density). In contrast,
in IdoA2S-containg hexasaccharides, the N-sulfation shifts the
VI-2 signal to lower parts per million (−0.07 ppm) due to in-
creased shielding (more electron density). Such different effects
suggest more complicated through space interactions between
the saccharide residues, which could involve the participation
of an IdoA2S or a GlcA2S residue; however, the available tech-
niques do not permit us to dissect these interactions.
As expected, 6-O-sulfation clearly shifts the proton reso-
nances of Residues II, IV and VI in both GlcA2S- and
IdoA2S-containing hexasaccharides (Tables I and II). The pres-
ence of 6-O-sulfation also affects the chemical environments of
the neighboring residues. For instance, Residue V in Construct
4 is flanked by two GlcNS6S resides (Residues IV and VI), the
signal of V-1 is shifted by +0.08 ppm in comparison with this
signal in Construct 3. Similarly, a chemical shift difference for
the V-1 proton was also observed (+0.07 ppm) between Constructs
6 and 7 (Tables I and II). These data suggest that the impact of
6-O-sulfation on the neighboring residues can be observed in
both GlcA2S- and IdoA2S-containing hexasaccharides.
The availability of 3-O-sulfated Construct 8 and non-3-O-
sulfated Construct 7 differentiates the impact of 3-O-sulfation on
the distribution of IdoA2S residue conformers. The 3-O-sulfation
on Residue IValters the conformation of its reducing-end IdoA2S
residue (Residue III) as demonstrated by changes in the coupling
constant of IdoA2S signals. For example, the 3JHH coupling con-
stants of III-1 and III-5 are larger in Construct 8 (3.7 Hz, 3.1 Hz)
than in Construct 7 (3.0 Hz, 2.7 Hz) (Supplementary data,
Figure S5), suggesting an increased proportion of 2S0 conform-
ation for Residue III in Construct 8. Indeed, Guerrini et al. (2013)
demonstrated that 3-O-sulfated glucosamine residue influences the
IdoA2S residue conformational equilibrium between 1C4 and
2S0.
Contribution of GlcA2S and IdoA2S to the binding affinity
of antithrombin
Heparin binds antithrombin (AT) to exert its anticoagulant
activity. Within heparin, a unique pentasaccharide sequence,
-GlcNS6S-GlcA-GlcNS3S6S-IdoA2S-GlcNS6S-, has been
Fig. 5. 2D 1H–13C HSQC–TOCSY NMR spectrum of Construct 3. 2D 1H–13C HSQC–TOCSY NMR experiment was employed to characterize the structure of
Construct 3. The signals of protons are indicated. The signals are connected with lines identifying correlated protons on each saccharide residue. The chemical
structure of Construct 3 is shown on top of the Figure.
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Table I. 1H–13C NMR chemical shift assignments (in ppm) of Constructs 1–4 (25°C, D2O, pD 7.0)
1 2 3 4 5 6a 6b
Construct 1 (GlcNH2-GlcA-GlcNS-GlcA-GlcNS-GlcA-pnp)
I 5.29/102.0 3.69/75.1 3.97/78.6 3.89/79.0 4.04/79.1
II 5.63/99.9 3.28/60.4 3.69/72.1 3.69/80.6 3.81/73.3 3.80/62.1 3.85/62.1
III 4.53/104.8 3.38/75.4 3.85/78.7 3.79/79.0 3.84/78.7
IV 5.60/99.9 3.25/60.4 3.68/72.1 3.68/80.5 3.79/73.2 3.80/62.1 3.85/62.1
V 4.50/104.8 3.40/75.9 3.75/78.6 3.82/78.7 3.87/78.6
VI 5.68/97.9 3.30/56.9 3.84/72.1 3.47/71.8 3.71/75.1 3.79/62.4 3.80/62.4
Construct 2 (GlcNH2-GlcA-GlcNS-GlcA2S-GlcNS-GlcA-pnp)
I 5.27/102.0 3.70/75.1 3.94/78.2 3.88/81.0 4.00/79.8
II 5.51/100.7 3.25/60.6 3.73/72.2 3.65/81.9 3.82/73.4 3.82/62.1 3.96/62.1
III 4.70/103.3 4.11/82.5 4.02/77.9 3.84/78.9 3.85/79.0
IV 5.64/99.9 3.22/60.3 3.67/72.4 3.67/80.6 3.81/73.3 3.84/62.1 3.85/62.1
V 4.49/104.9 3.39/75.9 3.75/78.6 3.77/78.7 3.83/78.6
VI 5.61/98.9 3.15/57.2 3.76/73.3 3.44/72.0 3.73/75.0 3.78/62.6 3.79/62.6
Construct 3 (GlcNS-GlcA-GlcNS-GlcA2S-GlcNS-GlcA-pnp)
I 5.31/102.0 3.70/75.0 3.95/78.1 3.89/80.5 4.11/78.9
II 5.54/100.7 3.26/60.5 3.73/72.0 3.66/81.7 3.78/73.5 3.81/62.0 3.96/62.0
III 4.71/103.2 4.12/82.4 4.01/77.7 3.88/78.8 3.90/78.6
IV 5.62/100.1 3.23/60.4 3.67/72.3 3.67/80.6 3.77/73.4 3.83/62.1 3.86/62.1
V 4.52/104.9 3.39/75.5 3.83/78.6 3.79/79.0 3.86/78.8
VI 5.61/100.1 3.21/60.8 3.58/73.9 3.45/72.3 3.66/74.4 3.76/62.8 3.78/62.8
Construct 4 (GlcNS6S-GlcA-GlcNS6S-GlcA2S-GlcNS6S-GlcA-pnp)
I 5.31/102.0 3.72/75.1 3.96/78.2 3.91/81.4 4.12/79.2
II 5.51/101.0 3.30/60.5 3.73/72.0 3.73/80.3 3.98/71.7 4.18/68.5 4.54/68.5
III 4.76/102.7 4.14/82.4 3.99/77.8 3.86/79.3 3.87/79.1
IV 5.62/100.2 3.25/60.2 3.69/72.3 3.73/79.7 3.99/71.5 4.19/68.5 4.43/68.5
V 4.60/104.6 3.38/75.6 3.85/78.7 3.81/79.6 3.87/79.0
VI 5.59/100.3 3.24/60.7 3.61/73.8 3.56/71.7 3.86/72.5 4.15/69.0 4.33/69.0
Table II. 1H–13C NMR chemical shift assignments (in ppm) of Constructs 5–8 (25°C, D2O, pD 7.0)
1 2 3 4 5 6a 6b
Construct 5 (GlcNH2-GlcA-GlcNS-IdoA2S-GlcNS-GlcA-pnp)
I 5.27/102.0 3.69/75.1 3.95/78.5 3.87/79.8 4.00/79.6
II 5.58/100.3 3.25/61.0 3.65/72.5 3.70/79.7 3.79/73.8 3.83/62.4 3.84/62.4
III 5.23/101.8 4.30/77.6 4.22/70.7 4.03/78.4 4.82/71.1
IV 5.30/99.8 3.23/60.5 3.71/72.2 3.66/80.5 3.90/73.3 3.84/62.3 3.86/62.3
V 4.50/104.8 3.41/75.9 3.74/78.6 3.83/78.7 3.83/78.8
VI 5.68/97.9 3.29/56.9 3.83/72.2 3.47/71.9 3.72/75.0 3.78/62.5 3.79/62.5
Construct 6 (GlcNS-GlcA-GlcNS-IdoA2S-GlcNS-GlcA-pnp)
I 5.28/102.0 3.70/75.1 3.96/78.5 3.88/79.7 4.02/79.4
II 5.59/100.3 3.26/61.0 3.66/72.4 3.70/79.8 3.80/73.8 3.84/62.3 3.84/62.3
III 5.26/101.8 4.32/77.2 4.24/70.3 4.03/78.4 4.92/70.7
IV 5.30/100.0 3.25/60.4 3.71/72.1 3.69/80.6 3.85/73.4 3.87/62.1 3.87/62.1
V 4.53/104.9 3.39/75.5 3.84/78.6 3.78/78.9 3.82/79.1
VI 5.62/100.0 3.22/60.8 3.59/73.9 3.45/72.4 3.68/74.4 3.77/62.9 3.77/62.9
Construct 7 (GlcNS6S-GlcA-GlcNS6S-IdoA2S-GlcNS6S-GlcA-pnp)
I 5.29/102.0 3.71/75.1 3.95/78.5 3.90/79.7 4.04/79.3
II 5.60/100.3 3.30/60.7 3.67/72.4 3.77/78.5 3.95/71.9 4.22/69.0 4.38/69.0
III 5.24/101.8 4.32/78.3 4.22/71.5 4.09/78.8 4.88/71.7
IV 5.40/99.6 3.28/60.2 3.69/72.1 3.74/79.7 4.05/71.6 4.22/68.6 4.44/68.6
V 4.60/104.5 3.38/75.5 3.84/78.6 3.78/79.4 3.82/79.0
VI 5.61/100.3 3.25/60.6 3.61/73.8 3.56/71.7 3.87/72.5 4.15/69.0 4.33/69.0
Construct 8 (GlcNS6S-GlcA-GlcNS3S6S-IdoA2S-GlcNS6S-GlcA-pnp)
I 5.28/102.0 3.70/75.1 3.96/78.5 3.90/80.0 4.02/79.4
II 5.58/100.4 3.29/60.8 3.67/72.4 3.78/79.7 3.96/72.0 4.22/69.0 4.43/69.0
III 5.23/102.2 4.31/79.6 4.17/72.8 4.14/78.5 4.83/72.8
IV 5.49/98.9 3.43/59.4 4.37/78.8 3.96/75.7 4.14/72.3 4.24/68.7 4.46/68.7
V 4.61/103.9 3.39/75.5 3.81/78.2 3.82/79.6 3.82/78.8
VI 5.60/100.3 3.23/60.7 3.60/73.9 3.56/71.7 3.86/72.5 4.14/69.0 4.34/69.0
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shown to display high-binding affinity. Previous work has sug-
gested that IdoA2S in this pentasaccharide domain contributes
to the binding of AT (Das et al. 2001). To confirm this conclu-
sion, the binding affinity to AT of the IdoA2S vs GlcA2S con-
structs was determined. Both 3-O-[35S]sulfated GlcA2S- and
IdoA2S-containing hexasaccharide were prepared for the analysis.
The results showed that IdoA2S-containing hexasaccharide binds
to ATwith a dissociation constant (Kd) of 12 ± 3 nM, whereas no
binding affinity was measurable for GlcA2S-containing hexa-
saccharide. Our result confirmed the essential role of IdoA2S in
AT binding.
Discussion
The GlcA2S residue is present in low abundance in heparin,
and thus, very limited information about the role of these rare
saccharide residues has been obtained. In this work, we demon-
strate the synthesis and structural characterization of highly
pure oligosaccharides containing GlcA2S. The synthesis of
three GlcA2S-containing hexasaccharides was completed
through a chemoenzymatic approach. The substrate specificity of
2-OST modifies only one of the two GlcA in the hexasacchar-
ides, allowing us to position the GlcA2S residue at the desired
site (Supplemetary data, Figure S1). Although the synthesis of a
number of HS hexasaccharides using a chemical and chemoen-
zymatic approach has been reported (Petitou and van Boeckel
1992; Liu et al. 2010), the synthesis of the GlcA2S-containing
hexasaccharide variants described in this research is novel.
The chemoenzymatic approach allows the construction of
diverse hexasaccharide analogs containing an AT-binding domain
to confirm the contribution of IdoA2S or GlcA2S residues to AT
binding affinity. Our data suggest that GlcA2S-containing hexa-
saccharides do not bind toAT, despite the fact that they carry
3-O- and 6-O-sulfo groups, confirming the previously reported
essential role of IdoA2S for high-affinity binding to AT (Jin
et al. 1997; Hricovini et al. 2001; Guerrini et al. 2010).
The NMR structural analysis data are consistent with the hy-
pothesis that GlcA2S is a relatively structural rigid unit in
heparin and HS compared with IdoA2S. The 3JHH coupling
Fig. 6. 1H–13C HMBC key correlations of Construct 3. 2D 1H–13C HMBC NMR experiment was employed to confirm the glycosidic linkages between each
saccharide unit of Construct 3. The signals of anomeric protons are indicated. The peaks are connected with lines identifying correlated carbon and proton. The
chemical structure of Construct 3 is shown on top of figure. Some other key 3JCH-correlations are shown as dashed lines on the chemical structure.
P-H Hsieh et al.
688
constants of GlcA ring protons in all constructs are 8.0 Hz as
reported previously as 4C1 form (Sattelle et al. 2010). In our
studies, the coupling constant of GlcA2S ring protons in the
synthesized hexasaccharide shows equal values, supporting the
conformation of GlcA2S remains predominately in the 4C1
form as well. In contrast, the protons of IdoA2S display smaller
coupling constants in the constructs, consistent with the fact
that the conformations of the IdoA2S residue are in the equilib-
rium between 2S0 and
1C4 forms.
The 2S0 conformation of IdoA2S is known to contribute to
AT-binding affinity (Hricovini et al. 2001; Guerrini et al. 2008,
2010). Indeed, IdoA2S-containing hexasaccharide displayed
high affinity with a Kd value of 12 nM, while no detectable
AT-binding affinity for GlcA2S-containing hexasaccharide was
observed. Importantly, the conformation of the IdoA2S residue
can be affected by the protein binding as well as interactions
with neighboring sulfated saccharide residues. For example,
binding of fibroblast growth factor 1 (FGF1) requires a 1C4
form of IdoA2S that is flanked by GlcNS6S residues (Faham
et al. 1996; DiGabriele et al. 1998; Kreuger et al. 2001);
however, in the absence of a nearby GlcNS6S residue, IdoA2S
can rearrange its conformation from a 2S0 to a
1C4 form which
binds FGF2 (Guglier et al. 2008; Zhang et al. 2008). Thus
IdoA2S conformation flexibility may play a role in orienting an
oligosaccharide for increased binding affinity to a specific
protein.
Using highly purified GlcA2S- and IdoA2S-containing hexa-
saccharides synthesized by the chemoenzymatic approach, we
successfully assign all the proton and carbon chemical shifts of
GlcA2S- and IdoA2S-containing oligosaccharides through 1D
and 2D NMR experiments. We compared the assignments
obtained from our study with the previously reported values. The
proton assignments of GlcA2S signals in this study are similar to
the previous reports, where the GlcA2S residue is flanked by
GlcNS6S and GlcNS residue in a tetrasaccharide (Yamada et al.
1995; Limtiaco et al. 2011; Ozug et al. 2012; Guerrini et al.
2013). The anomeric carbon assignment of GlcA2S was also
reported (Guerrini and Torri 2008), and our result is consistent
with the reported values. In the previous reports, only partial
assignments were achieved for the GlcA2S residues. Here, we
provide the full assignments for the GlcA2S residue within dif-
ferent sulfated saccharide contexts. The assignments for IdoA2S
are consistent with previous reports; however, an IdoA2S residue
flanked by two GlcNS3S6S residues shows significant differ-
ences in the proton and carbon assignments (Guerrini et al.
2013). The GlcNS3S6S residues may participate in the change
of chemical environment and conformation equilibrium of
neighboring IdoA2S residue, causing significant chemical shift
alterations.
Taking advantage of these chemical shift assignments, the
presence of GlcA2S can be easily distinguished from a mixture
of GlcA2S- and IdoA2S-containing oligosaccharides within an
NMR spectrum. 2D 1H–13C HSQC NMR is a powerful tool for
fingerprint the GlcA2S residue, and the 1H–13C correlation of
III-1 and III-2 position signals from this residue is easily ob-
servable (Supplementary data, Figure S4). The cross peak of
GlcA2S anomeric signal is also consistent to the signal
observed in enoxaparin (Guerrini and Torri 2008) or porcine in-
testinal heparin (Yamada et al. 1995), demonstrating the cap-
ability of using the 2D NMR fingerprint method to confirm the
authenticity of heparin drugs. Very interestingly, the anomeric
signals of GlcA2S were reportedly difficult to identify in unfractio-
nated heparin and low-molecular weight heparins; however, such
signals are visible in enoxaparin, a low-molecular weight heparin
manufactured by depolymerized unfractionated heparin under
basic conditions (Guerrini and Torri 2008; Keire et al. 2013).
Since the 2008 contaminated heparin crisis, NMR analysis
of heparin drug has become part of the heparin sodium US
Pharmacopeia monograph. Because heparin is a heterogeneous
polysaccharide mixture, the assignment of all of the signals is
difficult. To this end, acquiring the NMR spectra of highly puri-
fied heparin oligosaccharide standards provides a map for assign-
ing highly complex heparin spectra, especially those signals
from rare components. Our study should assist NMR analysis of
heparin to safeguard this widely used drug.
Materials and methods
Preparation of enzymes and cofactors
Escherichia coli was used for expression of all enzymes: KfiA,
pmHS2, NST, C5-epi, 2-OST, 6-OST-1, 6-OST-3 and 3-OST-1
for chemoenzymatic synthesis. Purification was completed by
appropriate affinity chromatography as described previously
(Xu et al. 2008; Liu et al. 2010). 3′-Phosphoadenosine
5′-phophosulfate (PAPS) is the sulfo donor, was prepared
from sodium sulfate and adenosine triphosphate (ATP) utilizing
ATP-sulfurylase and adenosine phosphokinase (Zhou et al.
2011). uridine diphosphate (UDP)-GlcNTFA was prepared
from glucosamine, followed by reaction with S-ethyltrifluorothio
acetate and protocol (Liu et al. 2010). GlcNTFAwas converted to
GlcNTFA-1-phosphate by N-acetylhexasamine-1-kinase (Zhao
et al. 2010) and subsequently transformed to UDP-GlcNTFA
using glucosamine-1-phosphate acetyltransferase/N-acetylglu
cosamine-1-phosphate uridyltransferase (Liu et al. 2010).
Table III. 1H NMR chemical shift difference (Δδ) by subtracting GlcA2S- from
IdoA2S-containing hexasaccharidesa
1 2 3 4 5 6a 6b
Construct 2 vs construct 5
I
II [+0.07] [−0.08] [−0.12]
III [+0.53] [+0.19] [+0.20] [+0.19] [+0.97]
IV [−0.34] [+0.09]
V
VI [+0.07] [+0.14] [+0.07]
Construct 3 vs construct 6
I [−0.09]
II [+0.05] [−0.07] [−0.12]




Construct 4 vs Construct 7
I [−0.08]
II [+0.09] [−0.06] [−0.16]




aListed values represent chemical shift difference ≥0.05 ppm.
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Synthesis of hexasaccharide intermediate
The elongation started from a commercial material, GlcA-pnp,
followed by elongation of GlcNTFA three times, elongation
of GlcA two times, and one detrifluoroacetylation and one
N-sulfation to make hexasaccharide intermediates (Supplementary
data, Figure S1). To introduce a GlcNTFA residue, GlcA-pnp (1.2
mM) was incubated with KfiA (20 µg/mL) in a buffer-containing
Tris (25 mM, pH 7.5), MnCl2 (15 mM) and UDP-GlcNTFA (1.5
mM), at room temperature overnight. To introduce a GlcA residue,
disaccharide substrate, GlcNTFA-GlcA-pnp (1.2 mM), was
incubated with pmHS2 (20 µg/mL) in a buffer-containing Tris
(25 mM, pH 7.5), MnCl2 (15 mM) and UDP-GlcA (1.5 mM),
at room temperature overnight. C18 column (0.75 × 20 cm;
Biotage) was used for purification with gradient elution (0–
100% acetonitrile in H2O, 0.1% trifluoroacetyl, 2 mL/min in
60 min). The eluted products were monitored by UV absorb-
ance at 310 nm and characterized by electrospray ionization
mass spectrometry (ESI-MS). The additional GlcNTFA and
GlcA elongation was repeated under the same condition.
Detrifluoroacetylation was completed using 0.1 M LiOH at 0°C
for 2 h. The products were analyzed by polyamine-based high-
performance liquid chromatography and ESI-MS. Afterwards,
N-sulfation was performed within pH 7.0 2-(N-morpholino)
ethanesulfonic acid (MES) (50 mM), N-sulfotransferase (10 µg/
mL) and PAPS (0.5 mM, 1.5 equiv. of substrate amount) at 37°C
overnight. The sulfated products were purified by Q-Sepharose
column (15 × 200 mm, GE Health Sciences) with linear gradient
elution (20–100% 1 M NaCl in 20 mM NaOAc, pH 5.0, flow
rate 2 mL/min) and followed by dialysis to obtain highly pure
hexasaccharide intermediates.
Synthesis of oligosaccharide Constructs 1–8
Detrifluoroacetylation of hexasaccharide intermediate could get
Construct 1. Constructs 2 and 5 were acquired by epimerization
and 2-O-sulfation within the solution contained MES (50 mM,
pH 7.0), CaCl2 (2 mM), C5-epi (10 µg/mL), 2-OST (10 µg/mL),
PAPS (0.2 mM) and hexasaccharide intermediate (0.13 mM)
at 37°C overnight. Following the procedure of N-sulfation
as described above could synthesize Constructs 3 and 6.
Construct 4 was obtained by 6-O-sulfation using PAPS
(800 µM), MES (50 mM, pH 7.0), 6-OST-1 (0.6 mg/mL) and
6-OST-3 (0.6 mg/mL) overnight at 37°C. Construct 7 was
obtained by 6-O-sulfation using PAPS (400 µM), MES (50
mM, pH 7.0), 6-OST-1 (0.1 mg/mL) and 6-OST-3 (0.1 mg/mL)
overnight at 37°C. 3-O-Sulfation was performed to synthesize
Construct 8 under the condition of MES (50 mM, pH 7.0),
MnCl2 (10 mM), MgCl2 (5 mM), 3-OST-1 (0.03 µg/mL) and
PAPS (600 µM) at 37°C overnight. The purification of Constructs
1–8 is essentially the same as the section “Synthesis of hexasac-
charide intermediate”.
Structural characterization of oligosaccharides
The purity of products was analyzed by polyamine-based
anion-exchange (PAMN)-HPLC or diethylethanolamine (DEAE)-
HPLC (Figure 2; Supplementary data, Figure S2 and S3). The
elution conditions were described in the previous literature (Liu
et al. 2010).
Mass spectrometric analyses were performed on all of the
intermediates and constructs by ESI-MS (Thermo LCQ-Deca)
with direct sample infusion from a syringe pump (Harvard
Apparatus). Each sample was diluted in 1:9 MeOH/H2O and
analyzed in negative ionization mode (3.5 kV, 150°C).
Xcalibur 1.3 was utilized to acquire and process full scanned
MS with 1 × 107 automatic gain control.
The structure of the oligosaccharides constructs and inter-
mediates was analyzed by NMR experiments, including 1D
(“s2pul” pulse sequence 1H or 13C) and 2D (1H–1H “gCOSY”
pulse sequence COSY, “TOCSY” pulse sequence TOCSY,
1H–13C “gHSQC” pulse sequence HSQC, “gHMBC” pulse se-
quence HMBC and “gHSQCTOXY” pulse sequence HSQC–
TOCSY) NMR. NMR experiments were performed at 298 K
on a Varian Inova 500 MHz spectrometer equipped with 5 mm
triple resonance XYZ or broadband PFG probe and processed
by VnmrJ 2.2D software. Chemical shifts are referenced to ex-
ternal 2,2-dimethyl-2-silapentane-5-sulfonate sodium salt
(Sigma, Co.). Deuterated EDTA (Sigma, Co.) was added to
resolve the coupling constants of IdoA2S signals. Samples
(5.0–10.0 mg) were each dissolved in 0.5 mL D2O (99.994%,
Sigma, Co.) and lyophilized three times to remove the ex-
changeable protons. The samples were re-dissolved in 0.5 mL
D2O and transferred to NMR microtubes (OD 5 mm, Norrell).
1D 1H NMR experiments were performed with 256 scans and
an acquisition time of 768 ms. 1D 13C NMR experiments were
performed with 40,000 scans, 1.0 s relaxation delay and an ac-
quisition time of 1000 ms. 2D (1H–1H COSY, TOCSY, 1H–13C
HSQC and HSQC–TOCSY) spectra were recorded with GARP
carbon decoupling, a 1.5 s relaxation delay, a 204 ms acquisi-
tion time with 500 increments for 48 scans. Forty-eight steady
state scans were used prior to the start of acquisition. A total of
2048 points were collected in f2. Gradients were used for coher-
ence transfer selection with sensitivity enhancement in the
HSQC experiment. 13C transmitter offset was set at 77.0 ppm.
The echo–anti-echo phase cycling scheme was used. The polar-
ization transfer delay was set with a 1JC–H coupling value of
147 Hz. 2D 1H–13C HMBC experiments were performed with
72 scans, 1.5 s relaxation delay and a 204 ms acquisition time.
The delay for evolution of long-range couplings was set with Jlr
of 7.6 Hz.
Determination of the binding affinity of
oligosaccharides to AT
35S-Labeled 3-O-sulfated constructs were prepared via
3-O-sulfation as described previously, using [35S]PAPS (0.5
nmol, specific activity 2.2 × 104 cpm/pmol) and oligosacchar-
ide precursor (5 µg) in total 500 μL at 37°C overnight. The pro-
ducts were purified by DEAE-HPLC column. Affinity
co-electrophoresis (Lee and Lander 1991) was used for meas-
urement of dissociation constant (Kd) of oligosaccharides.
35S-Labeled 3-O-sulfated constructs (1500–2500 cpm) were
loaded for lanes with AT concentration at 0, 8, 16, 32, 60, 120,
250, 500 and 1000 nM. The agarose gel was run with 300 mA
electrophoresis for 2 h and was dried at room temperature
overnight. The dried gel was analyzed by PhosphoImager
(Amersham Biosciences, Storm 860). The retardation coeffi-
cient was calculated at R = (M0 −M)/M0, whereM0 is the mobil-
ity of the oligosaccharide flow through in the lane without AT,
and M is the mobility of the sample in an individual lane. The
retardation coefficient was then plotted against the retardation
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coefficient divided by its respective AT concentration. The con-
stant −1/Kd is the slope of the trendline.
Supplementary data
Supplementary data for this article are available online at http://
glycob.oxfordjournals.org/.
Funding
This work is supported in part by Food and Drug
Administration grant U19FD004994 and National Institutes of
Health grants HL094463 and GM102137.
Conflict of interest statement
The findings and conclusions in this article have not been for-
mally disseminated by the Food & Drug Administration and
should not be construed to represent any Agency determination
or policy.
Abbreviations
AT, antithrombin; ATP, adenosine triphosphate; DEAE, diethy-
lethanolamine; ESI-MS, electrospray ionization mass spectrom-
etry; FGF1, fibroblast growth factor 1; GAG, glycosaminoglycans;
GlcA, D-glucuronic acid; GlcA2S, 2-O-sulfated glucuronic
acid; GlcA-pnp, 1-O-(para-nitrophenyl) glucuronide; GlcN,
D-glucosamine; HS, heparan sulfate; IdoA, L-iduronic acid;
IdoA2S, 2-O-sulfated iduronic acid; MES, 2-(N-morpholino)
ethanesulfonic acid; NMR, nuclear magnetic resonance; OST,
O-sulfotransferase; PAMN, polyamine-based anion exchange;
PAPS, 3′-phosphoadenosine 5′-phophosulfate; pnp, para-
nitrophenyl; TFA, trifluoroacetyl; UDP, uridine diphosphate.
References
Ahsan A, Jeske W, Hoppensteadt D, Lormeau JC, Wolf H, Fareed J. 1995.
Molecular profiling and weight determination of heparins and depolymerized
heparins. J Pharm Sci. 84(6):724–727.
Bishop JR, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans fine-
tune mammalian physiology. Nature. 446(7139):1030–1037.
Carlsson P, Presto J, Spillmann D, Lindahl U, Kjellen L. 2008. Heparin/heparan
sulfate biosynthesis: Processive formation of N-sulfated domains. J Biol
Chem. 283(29):20008–20014.
Casu B. 1985. Structure and biological activity of heparin. Adv Carbohydr
Chem Biochem. 43:51–134.
Das SK, Mallet JM, Esnault J, Driguez PA, Duchaussoy P, Sizun P, Herault JP,
Herbert JM, Petitou M, Sinay P. 2001. Synthesis of conformationally locked
L-iduronic acid derivatives: Direct evidence for a critical role of the skew-
boat 2S0 conformer in the activation of antithrombin by heparin. Chemistry.
7(22):4821–4834.
DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J,
Hendrickson WA. 1998. Structure of a heparin-linked biologically active
dimer of fibroblast growth factor. Nature. 393(6687):812–817.
Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC. 1996. Heparin struc-
ture and interactions with basic fibroblast growth factor. Science. 271
(5252):1116–1120.
Ferro DR, Provasoli A, Ragazzi M, Casu B, Torri G, Bossennec V, Perly B,
Sinay P, Petitou M, Choay J. 1990. Conformer populations of L-iduronic
acid residues in glycosaminoglycan sequences. Carbohydr Res. 195
(2):157–167.
Feyerabend TB, Li JP, Lindahl U, Rodewald HR. 2006. Heparan sulfate
C5-epimerase is essential for heparin biosynthesis in mast cells. Nat Chem
Biol. 2(4):195–196.
Griffin CC, Linhardt RJ, Van Gorp CL, Toida T, Hileman RE, Schubert RL,
2nd, Brown SE. 1995. Isolation and characterization of heparan sulfate from
crude porcine intestinal mucosal peptidoglycan heparin. Carbohydr Res. 276
(1):183–197.
Guerrini M, Elli S, Gaudesi D, Torri G, Casu B, Mourier P, Herman F, Boudier
C, Lorenz M, Viskov C. 2010. Effects on molecular conformation and anti-
coagulant activities of 1,6-anhydrosugars at the reducing terminal of
antithrombin-binding octasaccharides isolated from low-molecular-weight
heparin enoxaparin. J Med Chem. 53(22):8030–8040.
Guerrini M, Elli S, Mourier P, Rudd TR, Gaudesi D, Casu B, Boudier C, Torri
G, Viskov C. 2013. An unusual antithrombin-binding heparin octasaccharide
with an additional 3-O-sulfated glucosamine in the active pentasaccharide
sequence. Biochem J. 449(2):343–351.
Guerrini M, Guglieri S, Casu B, Torri G, Mourier P, Boudier C, Viskov C.
2008. Antithrombin-binding octasaccharides and role of extensions of the
active pentasaccharide sequence in the specificity and strength of interaction.
Evidence for very high affinity induced by an unusual glucuronic acid
residue. J Biol Chem. 283(39):26662–26675.
Guerrini M, Torri G. 2008. Quantitative 2D NMR analysis of glycosaminogly-
cans. In: Holzgrabe U, Diehl B and Wawer I, editors. NMR Spectroscopy in
Pharmaceutical Analysis. New York: Elsevier. p. 407–428.
Guglier S, Hricovini M, Raman R, Polito L, Torri G, Casu B, Sasisekharan R,
Guerrini M. 2008. Minimum FGF2 binding structural requirements of
heparin and heparan sulfate oligosaccharides as determined by NMR spec-
troscopy. Biochemistry. 47(52):13862–13869.
Hricovini M, Guerrini M, Bisio A, Torri G, Petitou M, Casu B. 2001.
Conformation of heparin pentasaccharide bound to antithrombin III.
Biochem J. 359(Pt 2):265–272.
Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. 1997. The anti-
coagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA. 94
(26):14683–14688.
Keire DA, Buhse LF, Al-Hakim A. 2013. Characterization of currently mar-
keted heparin products: Composition analysis by 2D-NMR. Anal Methods. 5
(12):2984–2994.
Kreuger J, Salmivirta M, Sturiale L, Gimenez-Gallego G, Lindahl U. 2001.
Sequence analysis of heparan sulfate epitopes with graded affinities for fibro-
blast growth factors 1 and 2. J Biol Chem. 276(33):30744–30752.
Langeslay DJ, Young RP, Beni S, Beecher CN, Mueller LJ, Larive CK. 2012.
Sulfamate proton solvent exchange in heparin oligosaccharides: Evidence
for a persistent hydrogen bond in the antithrombin-binding pentasaccharide
Arixtra. Glycobiology. 22(9):1173–1182.
Lee MK, Lander AD. 1991. Analysis of affinity and structural selectivity in the
binding of proteins to glycosaminoglycans: Development of a sensitive elec-
trophoretic approach. Proc Natl Acad Sci USA. 88(7):2768–2772.
Limtiaco JF, Beni S, Jones CJ, Langeslay DJ, Larive CK. 2011. The efficient
structure elucidation of minor components in heparin digests using microcoil
NMR. Carbohydr Res. 346(14):2244–2254.
Linhardt RJ. 2003. 2003 Claude S. Hudson Award address in carbohydr-
ate chemistry. Heparin: Structure and activity. J Med Chem. 46(13):
2551–2564.
Liu R, Xu Y, Chen M, Weiwer M, Zhou X, Bridges AS, DeAngelis PL, Zhang Q,
Linhardt RJ, Liu J. 2010. Chemoenzymatic design of heparan sulfate oligosac-
charides. J Biol Chem. 285(44):34240–34249.
Liu H, Zhang Z, Linhardt RJ. 2009. Lessons learned from the contamination of
heparin. Nat Prod Rep. 26(3):313–321.
McMahon AW, Pratt RG, Hammad TA, Kozlowski S, Zhou E, Lu S, Kulick
CG, Mallick T, Dal Pan G. 2010. Description of hypersensitivity adverse
events following administration of heparin that was potentially contaminated
with oversulfated chondroitin sulfate in early 2008. Pharmacoepidemiol
Drug Saf. 19(9):921–933.
Ozug J, Wudyka S, Gunay NS, Beccati D, Lansing J, Wang J, Capila I, Shriver
Z, Kaundinya GV. 2012. Structural elucidation of the tetrasaccharide pool in
enoxaparin sodium. Anal Bioanal Chem. 403(9):2733–2744.
Petitou M, van Boeckel CA. 1992. Chemical synthesis of heparin fragments
and analogues. Fortschr Chem Org Naturst. 60:143–210.
Sattelle BM, Hansen SU, Gardiner J, Almond A. 2010. Free energy landscapes
of iduronic acid and related monosaccharides. J Am Chem Soc. 132
(38):13132–13134.
Sommers CD, Ye H, Kolinski RE, Nasr M, Buhse LF, Al-Hakim A, Keire DA.
2011. Characterization of currently marketed heparin products: Analysis of
Characterization of GlcA2S-containing hexasaccharides
691
molecular weight and heparinase-I digest patterns. Anal Bioanal Chem. 401
(8):2445–2454.
Victor XV, Nguyen TK, Ethirajan M, Tran VM, Nguyen KV, Kuberan B. 2009.
Investigating the elusive mechanism of glycosaminoglycan biosynthesis. J Biol
Chem. 284(38):25842–25853.
Xu Y, Masuko S, Takieddin M, Xu H, Liu R, Jing J, Mousa SA, Linhardt RJ,
Liu J. 2011. Chemoenzymatic synthesis of homogeneous ultralow molecular
weight heparins. Science. 334(6055):498–501.
Xu D, Moon AF, Song D, Pedersen LC, Liu J. 2008. Engineering sulfotrans-
ferases to modify heparan sulfate. Nat Chem Biol. 4(3):200–202.
Yamada S, Murakami T, Tsuda H, Yoshida K, Sugahara K. 1995. Isolation of the
porcine heparin tetrasaccharides with glucuronate 2-o-sulfate – heparinase
cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated
blocks in heparin. J Biol Chem. 270(15):8696–8705.
Zhang Z, McCallum SA, Xie J, Nieto L, Corzana F, Jimenez-Barbero J, Chen M,
Liu J, Linhardt RJ. 2008. Solution structures of chemoenzymatically synthe-
sized heparin and its precursors. J Am Chem Soc. 130(39):12998–13007.
Zhao G, Guan W, Cai L, Wang PG. 2010. Enzymatic route to preparative-scale
synthesis of UDP-GlcNAc/GalNAc, their analogues and GDP-fucose. Nat
Protoc. 5(4):636–646.
Zhou X, Chandarajoti K, Pham TQ, Liu R, Liu J. 2011. Expression of
heparan sulfate sulfotransferases in Kluyveromyces lactis and prepar-
ation of 3′-phosphoadenosine-5′-phosphosulfate. Glycobiology. 21(6):
771–780.
P-H Hsieh et al.
692
